ストックスクリーナーアプリを入手
23.08
2.45%
-0.58
アフターアワーズ：
23.08
前日終値:
$23.66
開ける：
$23.82
24時間の取引高:
238.62K
Relative Volume:
0.51
時価総額：
$669.51M
収益：
$219.79M
当期純損益:
$-57.47M
株価収益率:
-10.73
EPS:
-2.15
ネットキャッシュフロー:
$-19.25M
1週間 パフォーマンス:
+1.58%
1か月 パフォーマンス:
+0.61%
6か月 パフォーマンス:
+19.59%
1年 パフォーマンス:
-18.45%
1日の値動き範囲:
$22.68
$23.82
1週間の範囲:
$22.27
$24.00
52週間の値動き範囲:
$14.59
$35.84
Castle Biosciences Inc Stock (CSTL) Company Profile
名前
Castle Biosciences Inc
セクター
電話
866-788-9007
住所
505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX
CSTL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CSTL
Castle Biosciences Inc
|
23.08 | 686.34M | 219.79M | -57.47M | -19.25M | -2.15 |
|
TMO
Thermo Fisher Scientific Inc
|
524.80 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
202.46 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
616.15 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
136.62 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
198.17 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-01-07 | 開始されました | Stephens | Overweight |
| 2021-04-30 | 開始されました | Lake Street | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2019-12-27 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-08-19 | 開始されました | BTIG Research | Buy |
| 2019-08-19 | 開始されました | Canaccord Genuity | Buy |
| 2019-08-19 | 開始されました | Robert W. Baird | Outperform |
| 2019-08-19 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Castle Biosciences Inc (CSTL) 最新ニュース
How high can Castle Biosciences Inc. stock go2025 Key Highlights & Weekly High Return Opportunities - newser.com
Using data tools to time your Castle Biosciences Inc. exitMarket Performance Report & Daily Price Action Insights - newser.com
Is Castle Biosciences Inc. stock poised for growthDividend Hike & Proven Capital Preservation Tips - newser.com
Is this a good reentry point in Castle Biosciences Inc.July 2025 PostEarnings & Consistent Return Investment Signals - newser.com
What drives Castle Biosciences Inc stock priceCup and Handle Formations & Free Expert Stock Watchlists - earlytimes.in
How to integrate Castle Biosciences Inc. into portfolio analysis toolsMarket Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Weiss Ratings Reiterates "Sell (E+)" Rating for Castle Biosciences (NASDAQ:CSTL) - MarketBeat
Castle Biosciences Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Castle Biosciences CEO Maetzold sells $30,234 in shares - Investing.com
Will Castle Biosciences Inc. stock pay special dividendsGDP Growth & Weekly Top Gainers Trade List - newser.com
How Castle Biosciences Inc. stock reacts to Fed rate cuts2025 Price Action Summary & Weekly Market Pulse Alerts - newser.com
Order flow analysis tools used on Castle Biosciences Inc.2025 Pullback Review & Daily Stock Trend Reports - newser.com
Analyzing net buyer seller activity in Castle Biosciences Inc.Trade Volume Summary & Verified Technical Trade Signals - newser.com
Is Castle Biosciences Inc a good long term investmentBollinger Bands Signals & Low Risk Investment Growth - earlytimes.in
Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine - markets.businessinsider.com
Castle Biosciences’ Founder, President and CEO Derek - GlobeNewswire
Selected from 586 Executives: Castle Biosciences' Derek Maetzold Crowned CEO of the Year 2025 - Stock Titan
User - FinancialContent
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
What analysts say about Castle Biosciences Inc stockSmall Cap Stock Opportunities & High Profit Market Tips - Early Times
Strs Ohio Takes $366,000 Position in Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences Honored with a Greater Pittsburgh Top Workplaces 2025 Award - markets.businessinsider.com
SciBase Receives Initial Order for Clinical Study From Castle Biosciences - 富途牛牛
Castle Biosciences (NASDAQ:CSTL) Insider Sells $29,417.83 in Stock - MarketBeat
Castle Biosciences, Inc. $CSTL Shares Sold by Goldman Sachs Group Inc. - MarketBeat
Diagnostic Testing Leader Castle Biosciences Secures 9th Workplace Award in 2025, Including Pittsburgh Honor - Stock Titan
SciBase receives initial order for clinical study from Castle Biosciences - Yahoo Finance
Scibase receives initial order for clinical study from Castle Biosciences - MarketScreener
Inspire Investing LLC Has $343,000 Holdings in Castle Biosciences, Inc. $CSTL - MarketBeat
Activity Recap: Does Castle Biosciences Inc have declining or rising EPSShare Buyback & Stepwise Trade Execution Plans - khodrobank.com
Risks Report: Can Castle Biosciences Inc deliver alphaJuly 2025 Chart Watch & High Conviction Buy Zone Picks - khodrobank.com
Aug Breakouts: How liquid is Castle Biosciences Inc stockJuly 2025 Spike Watch & Daily Entry Point Trade Alerts - خودرو بانک
Castle Biosciences Reports Strong Q2 2025 Financial Results - MSN
Castle Biosciences Inc (CSTL) 財務データ
収益
当期純利益
現金流量
EPS
0.17%
2.19%
大文字化:
|
ボリューム (24 時間):